• United Nations Approves Consultative Status for Susan G. Komen

    WASHINGTON, DC—August 16, 2013— Susan G. Komen is pleased to announce that the United Nations Economic and Social Council (ECOSOC) has granted Komen Special Consultative Status, allowing the world’s largest breast cancer organization to further advance its international work alongside the UN. ECOSOC was established by the UN Charter and is the principal organ to coordinate the economic, social and related work of the United Nations.

    Special Consultative Status enables key actors in civil society to play an active role in informing UN activities. With this new status, Komen staff will participate in the Council’s economic and social development meetings while also helping apprise the Council of developments in the incidence and potential for prevention, detection and treatment of breast cancer in the developing world.

    “This accreditation allows Komen to further share our knowledge and experience with the UN to address a growing cancer crisis in low-resource nations, and we are grateful for this recognition,” said Nancy G. Brinker, Susan G. Komen Founder and Chair of Global Strategy. “We look forward to working with the Council to make even more substantive contributions toward fighting breast cancer around the world.”

    The new ECOSOC designation builds on Komen’s past and ongoing work with the United Nations.   Brinker recently served two terms as the Goodwill Ambassador for Cancer Control for the UN’s World Health Organization.  Komen has also been working with UNAIDS since 2011 in Sub-Saharan Africa to leverage the HIV/AIDS platform to screen and treat cervical and breast cancer as founding members of the Pink Ribbon, Red Ribbon partnership.

    Komen began its global work in 1999. To date, Komen has granted $27 million for international breast cancer research grants and more than $15 million for international community education and outreach grants. Recent estimates indicate that the global burden of breast cancer is currently more than 1.6 million new cases annually and increasing at an annual rate of 3.1 percent. Despite major advances benefitting women in the Western world, breast cancer is too often detected at dangerously late stages in the developing world (Stages III and IV), and is far more deadly than breast cancer that is detected early. Recent studies in these countries indicate that 44% of breast cancer cases are in women under 50.